APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 260 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $65,000 | -69.3% | 950 | -77.3% | 0.00% | -71.4% |
| Q1 2022 | $212,000 | +488.9% | 4,181 | +449.4% | 0.01% | +600.0% |
| Q4 2021 | $36,000 | -87.8% | 761 | -91.5% | 0.00% | -90.0% |
| Q3 2021 | $296,000 | -22.7% | 8,979 | +48.2% | 0.01% | -16.7% |
| Q2 2021 | $383,000 | +2846.2% | 6,057 | +1289.2% | 0.01% | +1100.0% |
| Q3 2020 | $13,000 | -69.8% | 436 | -67.2% | 0.00% | -80.0% |
| Q2 2020 | $43,000 | +43.3% | 1,330 | +19.2% | 0.01% | -61.5% |
| Q1 2020 | $30,000 | +2900.0% | 1,116 | +2690.0% | 0.01% | – |
| Q3 2019 | $1,000 | -66.7% | 40 | -70.8% | 0.00% | -100.0% |
| Q1 2019 | $3,000 | 0.0% | 137 | -41.9% | 0.00% | 0.0% |
| Q4 2018 | $3,000 | – | 236 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |